EN
登录

印度医疗科技的下一个飞跃:推出MISSO——Meril的革命性膝关节置换机器人

India’s next leap in MedTech: Introducing MISSO – The revolutionary knee replacement robot by Meril

Medgate Today 等信源发布 2024-06-22 16:37

可切换为仅中文


3 out of 10 people above the age of 40 suffer from osteoarthritis of the knee in India.[i]

在印度,40岁以上的人中有10人中有3人患有膝关节骨关节炎。[我]

Out of about 32 lakh patients, who need knee replacement surgery every year, only 5 .5 lakhs undergo the surgery.

在每年需要膝关节置换手术的约3200万患者中,只有550万人接受了手术。

Robotic knee replacement surgery reduces recovery time, pain, and other complications as compared to conventional surgery.

与传统手术相比,机器人膝关节置换手术减少了恢复时间,疼痛和其他并发症。

MISSO is the first of its kind technology advanced Robot that can make robotic knee surgery available even in smaller hospitals and Tier 2 and 3 cities.

MISSO是同类技术先进的机器人中的第一个,它可以使机器人膝关节手术甚至在较小的医院以及二、三级城市也可用。

Meril, an India-based global medical device company, today announced the launch of its advanced surgical robotic technology, MISSO. MISSO is a high-quality robotic system entirely made in India that provides surgeons with real-time assistance during knee replacement procedures with unparalleled accuracy.

总部位于印度的全球医疗器械公司Meril今天宣布推出其先进的外科机器人技术MISSO。MISSO是一个完全由印度制造的高质量机器人系统,它在膝关节置换手术中为外科医生提供了无与伦比的实时帮助。

Indian hospitals currently depend on imported robotic technology for knee replacement surgeries which requires a significant investment. MISSO will reduce this investment by ~66%, making these surgeries more accessible and affordable. The versatile technology of MISSO can be adapted for other joint surgeries in the near future..

印度医院目前依赖进口机器人技术进行膝关节置换手术,这需要大量投资。MISSO将减少约66%的投资,使这些手术更容易获得和负担得起。MISSO的多功能技术可以在不久的将来适用于其他关节手术。。

Total knee replacement (TKR) is a surgical procedure that involves replacing a damaged or worn-out knee joint with an artificial joint made of metal and ultra-high molecular weight polyethylene. Knee replacement surgery is necessary for patients who suffer from severe osteoarthritis. This condition is highly prevalent in India, occurring in around 22 to 39 percent of the population.

全膝关节置换术(TKR)是一种外科手术,涉及用金属和超高分子量聚乙烯制成的人工关节替代受损或磨损的膝关节。对于患有严重骨关节炎的患者,膝关节置换手术是必要的。这种情况在印度非常普遍,约占人口的22%至39%。

Today about, ~5.5 lakh people undergo total knee replacement in India every year, which is 2.5 times the number of such procedures conducted annually about five years ago.  Although its adoption is on the rise, the need for knee replacement surgeries annually is 7-8 times higher than the current number of surgeries performed in India.

如今,印度每年约有550万人接受全膝关节置换术,是大约五年前每年进行此类手术数量的2.5倍。尽管其采用率正在上升,但每年膝关节置换手术的需求量比目前印度的手术数量高7-8倍。

Currently, only 20% of surgeons perform 80% of knee replacement surgeries (approx.)..

目前,只有20%的外科医生进行了80%的膝关节置换手术(约)。。

Mr. Manish Deshmukh, Head of Marketing, India & Global, at Meril, says, “Meril is pleased to bring MISSO, which has the potential to democratise robotic knee replacement surgery in India. The prevalence of osteoarthritis has surged from ~23 million to 62 million in the last 20-25 years, making it the second-largest disease modality after cardiovascular conditions.[ii] The gap between the need and adoption of knee replacement surgery can be addressed more efficiently by the widespread use of robotic surgery.

Meril印度和全球营销主管Manish Deshmukh先生说:“Meril很高兴带来MISSO,它有可能在印度民主化机器人膝关节置换手术。在过去的20-25年中,骨关节炎的患病率从约2300万激增到6200万,使其成为继心血管疾病之后的第二大疾病形式。[ii]机器人手术的广泛使用可以更有效地解决膝关节置换手术的需求和采用之间的差距。

Currently, the affordability of robotic surgery procedures is a challenge in India. Hospitals also hesitate to invest in imported robotic systems because it requires the training of surgeons and OT staff and a long turnaround time for service-related requests. With MISSO, we aim to address these challenges by providing the platform indigenously alongside an ecosystem of training and support that will make robotic surgery highly accessible, not only in metros but also in Tier 2 and Tier 3 cities”..

目前,机器人手术程序的负担能力在印度是一个挑战。医院也不愿投资进口机器人系统,因为这需要对外科医生和OT人员进行培训,并且需要很长的周转时间才能满足与服务相关的要求。有了MISSO,我们的目标是通过在本地提供平台以及培训和支持的生态系统来应对这些挑战,这将使机器人手术不仅在地铁,而且在二级和三级城市都非常容易获得”。。

“This launch reinforces our leadership in the segment of joint replacement surgeries and robotics in India. We are also actively exploring the export potential of this advanced robotic system to help India lead in making robotic surgery accessible worldwide,” he added.

他补充道:“此次发布巩固了我们在印度关节置换手术和机器人领域的领导地位。我们还积极探索这种先进机器人系统的出口潜力,以帮助印度在全球范围内领先机器人手术。”。

MISSO has received approval from CDSCO and is queued up for CE and USFDA approvals in times to come. Through the use of a robotic system, the success rate of knee replacement surgery is close to ~98%. The robotic system also helps surgeons who are relatively less experienced to achieve a similar degree of precision and accuracy as experienced surgeons.

MISSO已获得CDSCO的批准,并正在排队等待CE和USFDA的批准。通过使用机器人系统,膝关节置换手术的成功率接近98%。机器人系统还可以帮助经验相对较少的外科医生达到与经验丰富的外科医生相似的精确度和准确性。

This can help achieve a more even distribution of surgeries and greater standardization of treatment with a higher rate of positive outcomes across national health systems..

这可以帮助实现更均匀的手术分布和更高的治疗标准化,并在全国卫生系统中取得更高的积极成果。。

Dr Sujoy Bhattacharjee, HOD and Director at Robotic Joint Replacement, Sarvodaya Hospital, Faridabad, says, “In my practice, I have witnessed firsthand how innovations in robotic surgery have transformed patients’ lives. Robotic systems provide clear, and objective data before the surgery. This helps to bring personalization and customization for every patient’s specific needs, thereby greatly improving patient satisfaction post-surgery.

HOD博士、法里达巴德Sarvodaya医院机器人关节置换主任Sujoy Bhattacharjee说:“在我的实践中,我亲眼目睹了机器人手术的创新如何改变了患者的生活。机器人系统在手术前提供了清晰客观的数据。这有助于为每位患者的特定需求带来个性化和定制,从而大大提高患者术后满意度。

MISSO is set to reshape the robotic surgery landscape in India. This indigenous robotic system represents a significant breakthrough, offering advanced capabilities while being cost-efficient. I am confident that within the next five years, orthopedic robots will become commonplace in every district across India.

MISSO将重塑印度机器人手术的格局。这种本土机器人系统代表了一项重大突破,在提供先进功能的同时具有成本效益。我相信,在未来五年内,整形外科机器人将在印度各地普及。

This widespread adoption will ensure that more patients benefit from the superior outcomes associated with robotic-assisted procedures, raising the standard of healthcare nationwide.”.

这种广泛采用将确保更多患者受益于与机器人辅助手术相关的优越结果,从而提高全国医疗保健标准。”。

Misso has the smallest footprint in the OR as a robotic system for knee replacement, making it ideal for use even in small hospitals. The use of AI in this system reduces the pre-operative planning time by ~83% and improves personalisation. Other features of the product include increased precision and safety during the procedure.

Misso作为膝关节置换的机器人系统,在手术室中占地面积最小,因此即使在小型医院也非常适合使用。在该系统中使用AI可将术前计划时间减少约83%,并改善个性化。该产品的其他功能包括在操作过程中提高精度和安全性。

The level of personalisation contributes to better operative outcomes and reduced risk of complications. Patients can expect improved joint function and a quicker return to their daily activities, making knee replacement a less cumbersome procedure..

个性化程度有助于改善手术结果并降低并发症风险。患者可以期望关节功能得到改善,并更快地恢复日常活动,从而使膝关节置换术不那么麻烦。。